Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
INR 50.23
(0.0%)
INR 50.23
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 27.19 Million INR | -18.18% |
| 2022 | 28.13 Million INR | -5.12% |
| 2021 | 29.16 Million INR | 28.43% |
| 2020 | 23.17 Million INR | 22.58% |
| 2019 | 19.06 Million INR | -27.54% |
| 2018 | 26.65 Million INR | 4.29% |
| 2017 | 25.88 Million INR | 9.29% |
| 2016 | 24.15 Million INR | -23.49% |
| 2015 | 29.45 Million INR | -1.03% |
| 2014 | 30.03 Million INR | 26.71% |
| 2013 | 24.02 Million INR | 19.29% |
| 2012 | 19.86 Million INR | 8.27% |
| 2011 | 18.35 Million INR | 3.29% |
| 2010 | 17.76 Million INR | 14.04% |
| 2009 | 15.57 Million INR | -2.92% |
| 2008 | 16.04 Million INR | 11.17% |
| 2007 | 14.43 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.06 Million INR | -50.6% |
| 2023 FY | - INR | -18.18% |
| 2023 Q1 | 3.56 Million INR | -31.24% |
| 2023 Q2 | 9.12 Million INR | 155.82% |
| 2023 Q3 | 5.1 Million INR | -44.04% |
| 2023 Q4 | 6.04 Million INR | 18.34% |
| 2022 Q3 | 8.45 Million INR | -17.74% |
| 2022 FY | - INR | -5.12% |
| 2022 Q1 | 4.13 Million INR | -26.91% |
| 2022 Q2 | 10.28 Million INR | 148.78% |
| 2022 Q4 | 5.18 Million INR | -38.7% |
| 2021 Q2 | 8.31 Million INR | 10.17% |
| 2021 Q4 | 5.65 Million INR | -26.44% |
| 2021 FY | - INR | 28.43% |
| 2021 Q3 | 7.68 Million INR | -7.55% |
| 2021 Q1 | 7.54 Million INR | -5.96% |
| 2020 Q2 | 5.91 Million INR | 120.11% |
| 2020 FY | - INR | 22.58% |
| 2020 Q4 | 8.02 Million INR | 40.08% |
| 2020 Q1 | 2.68 Million INR | -10.43% |
| 2020 Q3 | 5.73 Million INR | -3.05% |
| 2019 Q3 | 4.34 Million INR | -27.83% |
| 2019 Q1 | 5.42 Million INR | 22.64% |
| 2019 Q4 | 2.99 Million INR | -30.99% |
| 2019 Q2 | 6.01 Million INR | 11.05% |
| 2019 FY | - INR | -27.54% |
| 2018 Q3 | 5.8 Million INR | -27.47% |
| 2018 FY | - INR | 4.29% |
| 2018 Q4 | 4.41 Million INR | -23.86% |
| 2018 Q2 | 8 Million INR | 4.37% |
| 2018 Q1 | 7.66 Million INR | -16.94% |
| 2017 FY | - INR | 9.29% |
| 2017 Q2 | 8.06 Million INR | 803.58% |
| 2017 Q3 | 9.74 Million INR | 20.9% |
| 2017 Q4 | 9.23 Million INR | -5.3% |
| 2017 Q1 | -1.14 Million INR | 79.78% |
| 2016 Q1 | 7.14 Million INR | -23.65% |
| 2016 FY | - INR | -23.49% |
| 2016 Q4 | -5.66 Million INR | -145.3% |
| 2016 Q2 | 11.7 Million INR | 63.89% |
| 2016 Q3 | 12.51 Million INR | 6.88% |
| 2015 Q1 | 6.41 Million INR | 50.08% |
| 2015 Q3 | 8.51 Million INR | 44.83% |
| 2015 Q4 | 9.35 Million INR | 9.95% |
| 2015 FY | - INR | -1.03% |
| 2015 Q2 | 5.87 Million INR | -8.42% |
| 2014 FY | - INR | 26.71% |
| 2014 Q4 | 4.27 Million INR | -46.15% |
| 2014 Q3 | 7.93 Million INR | 6.55% |
| 2014 Q2 | 7.45 Million INR | 25.42% |
| 2014 Q1 | 5.94 Million INR | 26.37% |
| 2013 Q3 | 5.76 Million INR | 21.11% |
| 2013 FY | - INR | 19.29% |
| 2013 Q4 | 4.7 Million INR | -18.48% |
| 2013 Q1 | 5.65 Million INR | 21.33% |
| 2013 Q2 | 4.76 Million INR | -15.76% |
| 2012 Q3 | 5.46 Million INR | -10.41% |
| 2012 Q1 | 5.35 Million INR | 3.62% |
| 2012 Q2 | 6.09 Million INR | 13.79% |
| 2012 Q4 | 4.65 Million INR | -14.73% |
| 2012 FY | - INR | 8.27% |
| 2011 FY | - INR | 3.29% |
| 2011 Q4 | 5.17 Million INR | 22.39% |
| 2011 Q3 | 4.22 Million INR | 0.0% |
| 2010 Q4 | -1.96 Million INR | 0.0% |
| 2010 FY | - INR | 14.04% |
| 2009 FY | - INR | -2.92% |
| 2009 Q4 | 5.03 Million INR | 0.0% |
| 2008 FY | - INR | 11.17% |
| 2008 Q4 | 3.53 Million INR | 0.0% |
| 2007 Q4 | 2.76 Million INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -4157.194% |
| Sastasundar Ventures Limited | -203.51 Million INR | 113.362% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -134.746% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 69.45% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 67.714% |
| Sunil Healthcare Limited | 93.07 Million INR | 70.785% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -64.626% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.31% |
| Zenith Healthcare Limited | 4.98 Million INR | -445.168% |
| Patidar Buildcon Limited | -5.52 Million INR | 592.092% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 68.952% |
| Roopa Industries Limited | 55.7 Million INR | 51.18% |
| Smruthi Organics Limited | 120.31 Million INR | 77.398% |
| Trident Lifeline Limited | 102.69 Million INR | 73.52% |
| Bacil Pharma Limited | -569.32 Thousand INR | 4876.4% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 122.058% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -71.273% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 118.002% |
| PANJON LTD. | 4.08 Million INR | -565.028% |
| Tyche Industries Limited | 128.2 Million INR | 78.79% |
| Trimurthi Limited | -2.47 Million INR | 1197.151% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 242.73% |
| Anuh Pharma Limited | 878.5 Million INR | 96.905% |
| Crestchem Limited | 30.33 Million INR | 10.356% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 351.368% |
| Zenlabs Ethica Limited | 27.09 Million INR | -0.358% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 92.972% |
| ANG Lifesciences India Limited | 90.66 Million INR | 70.006% |
| Parmax Pharma Limited | 22.93 Million INR | -18.553% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 93.009% |
| Deccan Health Care Limited | 37.5 Million INR | 27.497% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 87.445% |
| Norris Medicines Limited | -1.78 Million INR | 1624.147% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 89.301% |
| Veerhealth Care Limited | 15.99 Million INR | -70.009% |
| Makers Laboratories Limited | 25.81 Million INR | -5.35% |
| Lactose (India) Limited | 201.22 Million INR | 86.486% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 128.276% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 84.058% |
| Mercury Laboratories Limited | 101.18 Million INR | 73.126% |
| Gennex Laboratories Limited | 219.35 Million INR | 87.603% |
| PRAVEG LIMITED | 321.43 Million INR | 91.54% |
| Denis Chem Lab Limited | 224.84 Million INR | 87.906% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 95.545% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 92.803% |
| Colinz Laboratories Limited | 5.42 Million INR | -400.976% |
| Godavari Drugs Limited | 134.62 Million INR | 79.801% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 6797.783% |
| Zenotech Laboratories Limited | 172.64 Million INR | 84.249% |
| Panchsheel Organics Limited | 189.36 Million INR | 85.64% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 93.941% |
| Vivanza Biosciences Limited | 11.2 Million INR | -142.708% |
| Phaarmasia Limited | -1.58 Million INR | 1818.9% |
| Bharat Parenterals Limited | 265.74 Million INR | 89.767% |
| Medi-Caps Limited | 4.77 Million INR | -469.964% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 1099.743% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 96.728% |
| BDH Industries Limited | 124.27 Million INR | 78.118% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 183.983% |
| Coral Laboratories Limited | 227.07 Million INR | 88.025% |
| Concord Drugs Limited | 40.52 Million INR | 32.89% |
| Beryl Drugs Limited | 26.63 Million INR | -2.08% |
| Evoq Remedies Limited | 6.18 Million INR | -339.449% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 67.085% |
| Transchem Limited | 56.61 Million INR | 51.965% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -128.743% |
| Parnax Lab Limited | 243.59 Million INR | 88.837% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 39.307% |
| Kerala Ayurveda Limited | 70.78 Million INR | 61.585% |
| Cian Healthcare Limited | 122.56 Million INR | 77.814% |
| Trinity League India Limited | -26.25 Million INR | 203.581% |
| Syschem (India) Limited | 70.4 Million INR | 61.374% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 417.194% |
| Natural Capsules Limited | 219.9 Million INR | 87.634% |
| Auro Laboratories Limited | 121.73 Million INR | 77.662% |